Fusaramin, an antimitochondrial compound produced by Fusarium sp., discovered using multidrug-sensitive Saccharomyces cerevisiae

J Antibiot (Tokyo). 2019 Sep;72(9):645-652. doi: 10.1038/s41429-019-0197-5. Epub 2019 Jun 17.

Abstract

A new compound, fusaramin (1), along with three known compounds, sambutoxin (2), N-demethylsambutoxin (3) and (-)-6-deoxyoxysporidinone (4), was isolated from a culture broth of Fusarium sp. FKI-7550 by bioassay-guided fractionation using multidrug-sensitive Saccharomyces cerevisiae 12geneΔ0HSR-iERG6. The chemical structure of 1 was elucidated by NMR studies and electronic circular dichroism spectrum. Compound 1 showed antibacterial activity against some Gram-positive and Gram-negative bacteria and inhibited the growth of S. cerevisiae 12geneΔ0HSR-iERG6 grown on glycerol-containing medium. The MICs of 1 against wild-type and multidrug-sensitive yeasts grown on glycerol-containing medium were >128 μg ml-1 and 0.64 μg ml-1, respectively. However, MICs of 1 against both yeast strains grown on glucose-containing medium were >128 μg ml-1. All compounds showed inhibition of ATP synthesis via oxidative phosphorylation using isolated S. cerevisiae mitochondria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / isolation & purification*
  • Circular Dichroism
  • Fusarium / growth & development
  • Fusarium / metabolism*
  • Gram-Negative Bacteria / drug effects
  • Gram-Positive Bacteria / drug effects
  • Magnetic Resonance Spectroscopy
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Saccharomyces cerevisiae / drug effects*

Substances

  • Anti-Infective Agents